v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jul. 31, 2026
Jul. 31, 2025
Cash flows from operating activities    
Net loss $ (227,313) $ (169,543)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Stock-based compensation expense 139,000 17,642
Depreciation and amortization 20,647 25,497
Amortization of deferred contract acquisition costs 31,944 25,347
Non-cash operating lease expenses 7,499 6,532
(Accretion of discount) amortization of premium on investments (4,737) (454)
Loss on changes in fair value of convertible notes 38,753 77,402
Other (13) 210
Changes in operating assets and liabilities:    
Accounts receivable (29,693) 47,793
Inventories 60 113
Deferred contract acquisition costs (41,522) (34,320)
Prepaid expenses and other current assets 587 (6,831)
Other non-current assets 2,009 1,769
Accounts payable 10,110 4,535
Accrued compensation and benefits (23,338) (7,194)
Operating lease liabilities (7,742) (5,917)
Accrued expenses and other current liabilities 7,338 8,939
Deferred revenue (5,183) 16,070
Other non-current liabilities 11,142 1,124
Net cash (used in) provided by operating activities (70,452) 8,714
Cash flows from investing activities    
Purchases of property and equipment (15,162) (9,038)
Capitalized internal-use software (1,349) (1,873)
Purchases of intangible assets (2,300) 0
Purchases of marketable securities (689,633) (22,386)
Proceeds from maturities of marketable securities 568,090 52,901
Net cash (used in) provided by investing activities (140,354) 19,604
Cash flows from financing activities    
Proceeds from issuance of common stock under employee stock purchase plan 12,272 0
Proceeds from issuance of common stock upon exercise of stock options 15,299 21,257
Payments for withholding taxes upon settlement of equity awards (28,403) 0
Payments for holdback consideration on business combination (981) (1,197)
Payments for deferred offering costs 0 (3,579)
Net cash (used in) provided by financing activities (1,813) 16,481
Net (decrease) increase in cash, cash equivalents, and restricted cash (212,619) 44,799
Cash, cash equivalents, and restricted cash, beginning of period 433,769 167,197
Cash, cash equivalents, and restricted cash, end of period 221,150 211,996
Supplemental disclosure of cash flow information:    
Cash paid for amount included in the measurement of operating lease liabilities 8,604 7,644
Non-cash investing and financing activities:    
Stock-based compensation capitalized in internal-use software 520 39
Property and equipment purchased but not yet paid 2,708 278
Vesting of early exercised stock options 0 458
Deferred offering costs accrued but not yet paid $ 0 $ 448